These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27028868)

  • 1. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
    Cuesta R; Holz MK
    Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).
    Reipas KM; Law JH; Couto N; Islam S; Li Y; Li H; Cherkasov A; Jung K; Cheema AS; Jones SJ; Hassell JA; Dunn SE
    Oncotarget; 2013 Feb; 4(2):329-45. PubMed ID: 23593654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3.
    Galan JA; Geraghty KM; Lavoie G; Kanshin E; Tcherkezian J; Calabrese V; Jeschke GR; Turk BE; Ballif BA; Blenis J; Thibault P; Roux PP
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):E2918-27. PubMed ID: 25002506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
    Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
    Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity.
    Jin YY; Andrade J; Wickstrom E
    PLoS One; 2015; 10(12):e0142574. PubMed ID: 26629823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability.
    Jadaliha M; Gholamalamdari O; Tang W; Zhang Y; Petracovici A; Hao Q; Tariq A; Kim TG; Holton SE; Singh DK; Li XL; Freier SM; Ambs S; Bhargava R; Lal A; Prasanth SG; Ma J; Prasanth KV
    PLoS Genet; 2018 Nov; 14(11):e1007802. PubMed ID: 30496290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses.
    Kroczynska B; Sharma B; Eklund EA; Fish EN; Platanias LC
    Mol Cell Biol; 2012 Jul; 32(14):2809-22. PubMed ID: 22586265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells.
    Matsuhashi S; Hamajima H; Xia J; Zhang H; Mizuta T; Anzai K; Ozaki I
    Cell Signal; 2014 Mar; 26(3):603-10. PubMed ID: 24334270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Implications of RSK1-3 in Human Breast Cancer.
    Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RSK1 promotes murine breast cancer growth and metastasis.
    Czaplinska D; Gorska M; Mieczkowski K; Peszynska-Sularz G; Zaczek AJ; Romanska HM; Sadej R
    Folia Histochem Cytobiol; 2018; 56(1):11-20. PubMed ID: 29498411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
    Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
    Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of RSK substrates using an analog-sensitive kinase approach.
    Lizcano-Perret B; Vertommen D; Herinckx G; Calabrese V; Gatto L; Roux PP; Michiels T
    J Biol Chem; 2024 Mar; 300(3):105739. PubMed ID: 38342435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.
    González-Ortiz A; Pulido-Capiz A; Castañeda-Sánchez CY; Ibarra-López E; Galindo-Hernández O; Calderón-Fernández MA; López-Cossio LY; Díaz-Molina R; Chimal-Vega B; Serafín-Higuera N; Córdova-Guerrero I; García-González V
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
    Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
    Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein.
    Jin C; Rajabi H; Rodrigo CM; Porco JA; Kufe D
    Oncogene; 2013 Apr; 32(17):2179-88. PubMed ID: 22689062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
    Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
    Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of eukaryotic translation initiation factor 4B (EIF4B) by open reading frame 45/p90 ribosomal S6 kinase (ORF45/RSK) signaling axis facilitates protein translation during Kaposi sarcoma-associated herpesvirus (KSHV) lytic replication.
    Kuang E; Fu B; Liang Q; Myoung J; Zhu F
    J Biol Chem; 2011 Dec; 286(48):41171-41182. PubMed ID: 21994950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
    Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
    Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.